TEON THERAPEUTICS
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.
TEON THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.teontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 486 1902
Email Addresses:
[email protected]
Total Funding:
37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress AJAX Libraries API Cloudflare WordPress 6.0 Cloudflare SSL Typekit
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oceanpine Capital
Oceanpine Capital investment in Series A - Teon Therapeutics
Oriental Fortune Capital
Oriental Fortune Capital investment in Series A - Teon Therapeutics
Oriza Ventures
Oriza Ventures investment in Series A - Teon Therapeutics
Kaitai Capital
Kaitai Capital investment in Series A - Teon Therapeutics
Lifespan Investments
Lifespan Investments investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Seed Round - Teon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-08 | Teon Therapeutics Names Serge Messerlian as CEO |
Official Site Inspections
http://www.teontherapeutics.com
- Host name: 49.119.215.35.bc.googleusercontent.com
- IP address: 35.215.119.49
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Teon Therapeutics"
Oncology Drug Development | Who We Are | Teon โฆ
Teon has assembled a powerhouse leadership team with a track record in oncology drug development and deep insights in G-protein coupled receptor (GPCR) signaling, small molecule design, along with a clear vision to push the โฆSee details»
Teon Therapeutics - Crunchbase Company Profile & Funding
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the โฆSee details»
Teon Therapeutics Inc. | LinkedIn
Teon Therapeutics Inc. Biotechnology Redwood City, California 1,105 followers Teon is a clinical company targeting metabolic signaling pathways and pioneering the development of GPCR therapiesSee details»
Teon Therapeutics - Craft
Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity. Its pipeline targets unexploited metabolic โฆSee details»
Teon Therapeutics Inc. Research by SuperAGI
```report ## Company Overview **Teon Therapeutics Inc.** is a dynamic clinical-stage biopharmaceutical firm based in Redwood City, California. Dedicated to the advancement of โฆSee details»
Teon Therapeutics, Inc. - VentureRadar
Teon Therapeutics is a private biopharma company developing a novel pipeline of GPCR-targeting small molecules for use in oncology. GPCRs are a... ... Find out more ...See details»
Teon Therapeutics - Overview, News & Similar companies
Nov 1, 2022 www.teontherapeutics.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Teon Therapeutics Announces Clinical Trial Collaboration โฆSee details»
Teon Therapeutics - PitchBook
Www.teontherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 555 Twin Dolphin Drive; Suite 120; Redwood City, CA 94065; United StatesSee details»
TEON THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TEON THERAPEUTICS, INC. of Redwood City, CA. Get the latest business insights from Dun & โฆSee details»
Our Team | Experts in Tumor Metabolism | Teon Therapeutics
As a member of BIO Board of Directors (the trade organization of biotech companies) from 1999 to 2009, Dr. Lange led the largest committee of member companies for two years and was โฆSee details»
Teon Therapeutics Inc. Overview | SignalHire Company Profile
Teon is a clinical-stage company targeting metabolic signaling pathways and pioneering the development of GPCR immunotherapies in difficult-to-treat cancers.See details»
Teon Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Teon Therapeutics Inc of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Teon Therapeutics, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.teontherapeutics.com. โฆSee details»
Teon Therapeutics Names Serge Messerlian as CEO
Mar 8, 2022 Teon completed its $30M Series A financing round in February 2021. For more information about Teon Therapeutics, please visit: www.teontherapeutics.com. Media Contact: โฆSee details»
Teon Therapeutics Names Serge Messerlian as CEO
Mar 8, 2022 For more information about Teon Therapeutics, please visit: www.teontherapeutics.com. Contacts Shani Lewis LaVoieHealthScience Email: โฆSee details»
Teon Therapeutics, Inc. (Teon Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a clinical-stage leader in AI/machine learning-enabled engineering โฆSee details»
Teon raises $30 million for cancer drugs - Chemical & Engineering โฆ
Mar 5, 2021 Teon Therapeutics, a small-molecule cancer drug start-up in San Francisco, has raised $30 million in series A financing to take its lead candidate into clinical trials.See details»
Organon acquires Actemra biosimilarโs US rights from Biogen
13 hours ago In September 2023, Biogen announced the receipt of US Food and Drug Administration (FDA) approval for Tofidence. The biosimilarโs commercialisation and licence โฆSee details»
Invest in Cancer | Teon Therapeutics | 20+ Years Experience
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of oral, GPCR-targeted small molecules โฆSee details»
Disease Modifying in Neurodegenerative Disease Treatment: An โฆ
Mar 12, 2025 NeuroSense Therapeutics, led by CEO and founder Alon Ben-Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a โฆSee details»